216 related articles for article (PubMed ID: 15924502)
1. Hormone replacement therapy and risk of acute myocardial infarction : a review of the literature.
Bromley SE; de Vries CS; Thomas D; Farmer RD
Drug Saf; 2005; 28(6):473-93. PubMed ID: 15924502
[TBL] [Abstract][Full Text] [Related]
2. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
Beral V; Banks E; Reeves G
Lancet; 2002 Sep; 360(9337):942-4. PubMed ID: 12354487
[TBL] [Abstract][Full Text] [Related]
3. Myocardial infarction risk and hormone replacement: differences between products.
de Vries CS; Bromley SE; Farmer RD
Maturitas; 2006 Feb; 53(3):343-50. PubMed ID: 16040209
[TBL] [Abstract][Full Text] [Related]
4. Post menopausal hormone replacement therapy and risk of acute myocardial infarction--a case control study of women in the East Midlands, UK.
Chilvers CE; Knibb RC; Armstrong SJ; Woods KL; Logan RF
Eur Heart J; 2003 Dec; 24(24):2197-205. PubMed ID: 14659771
[TBL] [Abstract][Full Text] [Related]
5. [Primary and secondary prevention of cardiovascular events through hormone replacement therapy (HRT)].
Pilz H
Wien Med Wochenschr; 2005 Sep; 155(17-18):397-403. PubMed ID: 16392437
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and risk of nonfatal acute myocardial infarction in Italy.
Tavani A; Bertuzzi M; Gallus S; Negri E; La Vecchia C
J Clin Epidemiol; 2005 Jul; 58(7):747-50. PubMed ID: 15939229
[TBL] [Abstract][Full Text] [Related]
7. Hormone therapy and cardiovascular disease: a systematic review and meta-analysis.
Magliano DJ; Rogers SL; Abramson MJ; Tonkin AM
BJOG; 2006 Jan; 113(1):5-14. PubMed ID: 16398764
[TBL] [Abstract][Full Text] [Related]
8. Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study.
Bretler DM; Hansen PR; Abildstrøm SZ; Jørgensen CH; Sørensen R; Hansen ML; Schramm TK; Løkkegaard E; Torp-Pedersen C; Gislason GH
Br J Clin Pharmacol; 2011 Jan; 71(1):105-15. PubMed ID: 21143506
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trial.
Tackett AH; Bailey AL; Foody JM; Miller JM; Apperson-Hansen C; Ohman EM; Hochman JS; Karnash SL; Califf RM; Topol EJ; Moliterno DJ
Am Heart J; 2010 Oct; 160(4):678-84. PubMed ID: 20934562
[TBL] [Abstract][Full Text] [Related]
10. [Menopause and hormone replacement therapy (HRT) in women with diabetes].
Cyganek K
Przegl Lek; 1999; 56(5):362-71. PubMed ID: 10554574
[TBL] [Abstract][Full Text] [Related]
11. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
[TBL] [Abstract][Full Text] [Related]
12. A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study.
Clarke SC; Kelleher J; Lloyd-Jones H; Slack M; Schofiel PM
BJOG; 2002 Sep; 109(9):1056-62. PubMed ID: 12269682
[TBL] [Abstract][Full Text] [Related]
13. Continuation of hormone replacement therapy during acute myocardial infarction after the women's health initiative study. Is it the time for change?
Yosefy C; Feingold M
Int J Cardiol; 2006 Mar; 107(3):293-8. PubMed ID: 16503250
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal hormone use in women with acute coronary syndromes.
Parsons E; Newby LK; Bhapkar MV; Alexander KP; White HD; Shah SH; Bushnell CD; Califf RM;
J Womens Health (Larchmt); 2004 Oct; 13(8):863-71. PubMed ID: 15671702
[TBL] [Abstract][Full Text] [Related]
15. Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up.
Alexander KP; Newby LK; Hellkamp AS; Harrington RA; Peterson ED; Kopecky S; Langer A; O'Gara P; O'Connor CM; Daly RN; Califf RM; Khan S; Fuster V
J Am Coll Cardiol; 2001 Jul; 38(1):1-7. PubMed ID: 11451256
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy and menopause: a review of randomized, double-blind, placebo-controlled trials.
Chang C; Lin CH
Kaohsiung J Med Sci; 2003 Jun; 19(6):257-70. PubMed ID: 12873034
[TBL] [Abstract][Full Text] [Related]
17. Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women's Health Initiative studies.
Shapiro S
Climacteric; 2006 Dec; 9(6):416-20. PubMed ID: 17085373
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease risk and hormone replacement therapy (HRT): a review based on randomised, controlled studies in postmenopausal women.
van Baal WM; Kooistra T; Stehouwer CD
Curr Med Chem; 2000 May; 7(5):499-517. PubMed ID: 10702621
[TBL] [Abstract][Full Text] [Related]
19. The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study.
Douketis JD; Julian JA; Crowther MA; Kearon C; Bates SM; Barone M; Piovella F; Middeldorp S; Prandoni P; Johnston M; Costantini L; Ginsberg JS
Clin Appl Thromb Hemost; 2011; 17(6):E106-13. PubMed ID: 21159708
[TBL] [Abstract][Full Text] [Related]
20. The impact of coronary heart disease in determining use of hormone replacement therapy in a general practice population.
Chin BS; Futaba K; Jethwa A; Lip GY
Int J Clin Pract; 2001 Oct; 55(8):515-8. PubMed ID: 11695070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
